Amy Schumer Shares Positive Experience with Mounjaro After Struggles with Ozempic Side Effects

Amy Schumer’s journey with the weight-loss medication Mounjaro stands in stark contrast to her previous experiences with Ozempic. In a recent Instagram video, the comedian expressed her positive feelings about Mounjaro, also known as tirzepatide, while addressing her nearly 13 million followers.

Reflecting on a Difficult Past

At age 43, Schumer recalled her earlier attempt to lose weight using Ozempic. She experienced severe side effects, leading her to stop the medication altogether. The comedian described her reaction to the medication: intense nausea and exhaustion that left her feeling bedridden. During this period, Schumer struggled with significant discomfort and health challenges.

A Candid Admission

“I wanted to share and keep it real with you all,” Schumer said in her Instagram clip filmed in her car. “Three years ago, I tried WeGovy, and it made me nauseous to the point of vomiting.” Her candidness highlights how some medications affect individuals differently.

Finding New Hope with Mounjaro

In her new experience with Mounjaro, Schumer reported a much improved reaction. She attributed this change to a telehealth consultation with MidiHealth, which offered an affordable way for her to explore this new treatment option. “I took a chance because I wanted to recommend it to my friends in the medical field,” she mentioned, emphasizing her desire to share helpful resources.

Alongside Mounjaro, Schumer has adopted a new health regimen that includes hormone treatments. She revealed, “They placed me on estrogen and progesterone because I was in perimenopause, and my symptoms have disappeared.” This combination of medications has reportedly led to beneficial changes in her overall health.

Enhanced Well-Being

Schumer highlighted noticeable improvements in her quality of life since starting her new treatment. “My hair is fuller, my skin has improved, and I have more energy,” she said, adding a lighthearted note about her renewed desire for intimacy. “I want to get down more, if you know what I mean.”

With a positive outlook, she stated, “Mounjaro’s been great. I’m truly having a good experience with it, and I wanted to keep it real with all of you.”

Investing in the Future

Schumer’s satisfaction with her experience led her to invest in MidiHealth, showcasing her trust in the company and its services. This move underscores her commitment to not only personal wellness but also to supporting healthcare advancements.

A Light-Hearted Farewell

As she ended her video, Schumer posed a playful question regarding the royal family, injecting her signature humor into the conversation. “Why don’t we have to call Kate Middleton Kate of Wales?” she quipped, before signing off with a light mention of her friend Hilaria.